Your browser doesn't support javascript.
loading
Toxicity Evaluation of Purna Cantirotaya Centuram, a Siddha Medicine in Wistar Rats.
Chitra, B; Ramaswamy, R S; Suba, V.
Afiliação
  • Chitra B; National Institute of Siddha, Tambaram Sanatorium, Chennai 600047, India.
  • Ramaswamy RS; Central Council for Research in Siddha, Arumbakkam, Chennai 600106, India.
  • Suba V; National Institute of Siddha, Tambaram Sanatorium, Chennai 600047, India.
Int Sch Res Notices ; 2015: 473296, 2015.
Article em En | MEDLINE | ID: mdl-27347522
ABSTRACT
Purna Cantirotaya Centuram (PCC), a herbometallic formulation of Siddha medicine, consists of mercury, sulphur, and gold, processed with red cotton flower and plantain stem pith juices. To evaluate its safety, acute and 28-day repeated oral toxicity studies were performed following OECD test guidelines 423 and 407, respectively. In acute study, PCC was administered orally at 5, 50, 300, and 2000 mg/kg body weight. Animals were observed for toxic signs for 14 days. Gross pathology was performed at the end of the study. In repeated dose toxicity study, PCC was administered at 2.5, 25, and 50 mg/kg body weight daily for 28 days. Satellite groups (control and high dose) were also maintained to determine the delayed onset toxicity of PCC. In acute toxicity study, no treatment related death or toxic signs were observed. It revealed that the LD50 cut-off value of PCC is between 2000 and 5000 mg/kg body weight. The repeated dose study did not show evidence of any treatment related changes in all observations up to the high dose level, when compared with the control. Histopathological examination revealed no abnormalities except mild hyperplasia of stomach in high dose group. This study provides scientific validation for the safety of PCC.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2015 Tipo de documento: Article